Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.
Department of Prostate Brachytherapy, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.
Clin Exp Nephrol. 2023 Nov;27(11):941-950. doi: 10.1007/s10157-023-02382-6. Epub 2023 Jul 27.
The stepwise initiation of peritoneal dialysis (PD) using Moncrief and Popovich's technique (SMAP) for catheter insertion is recommended for the systemic introduction of PD and prevention of catheter-related infections. In this study, we investigated patient outcomes in patients who underwent insertion of a PD catheter with a direct method versus the SMAP method.
We enrolled 295 consecutive patients who underwent PD as a primary renal replacement therapy and underwent insertion of a PD catheter at our institute between 2006 and 2021. We retrospectively reviewed their data and investigated patient outcomes, including mortality and PD catheter-related complications.
Median age at PD induction was 65 years in the direct insertion group and 65 years in the SMAP group (P = 0.80). The rate of PD introduction after emergency hemodialysis was significantly higher in the direct insertion group than in the SMAP group (P < 0.001). There was no significant difference in survival between the direct insertion and SMAP groups during the median follow-up period of 54 months (P = 0.12). Additionally, patients who transitioned to hemodialysis or kidney transplantation after PD showed significantly longer survival (P < 0.001). The incidence of PD catheter-related complications was not significantly different between the two groups. A body mass index ≥ 23 kg/m was an independent risk factor for peritonitis and exit-site infection (P = 0.006 and P = 0.011, respectively).
Planned sequential renal replacement therapy including hybrid hemodialysis, complete hemodialysis, and kidney transplantation after PD is important for improving patient outcomes. PD catheter insertion by SMAP may not be mandatory in our clinical practice.
Moncrief 和 Popovich 技术(SMAP)用于导管插入的逐步启动腹膜透析(PD)被推荐用于 PD 的系统引入和预防导管相关感染。在这项研究中,我们调查了直接法与 SMAP 法插入 PD 导管的患者的结局。
我们纳入了 2006 年至 2021 年在我们机构接受 PD 作为原发性肾脏替代治疗并接受 PD 导管插入的 295 例连续患者。我们回顾性分析了他们的数据,并调查了患者的结局,包括死亡率和 PD 导管相关并发症。
直接插入组 PD 诱导时的中位年龄为 65 岁,SMAP 组为 65 岁(P = 0.80)。直接插入组在急诊血液透析后开始 PD 的比例明显高于 SMAP 组(P < 0.001)。在中位随访 54 个月期间,直接插入组和 SMAP 组之间的生存没有显著差异(P = 0.12)。此外,PD 后转为血液透析或肾移植的患者生存时间明显延长(P < 0.001)。两组 PD 导管相关并发症的发生率无显著差异。BMI≥23 kg/m是腹膜炎和出口部位感染的独立危险因素(P = 0.006 和 P = 0.011)。
包括混合血液透析、完全血液透析和 PD 后肾移植在内的计划序贯肾脏替代治疗对于改善患者结局很重要。在我们的临床实践中,SMAP 可能不是 PD 导管插入的强制性要求。